About: Centalun

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Centalun was developed by Boehringer Ingelheim in 1962 and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor. It was previously used for sedation in medical procedures such as surgery, orthopedics and gynecology, although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse.

Property	Value
dbo:abstract	Centalun was developed by Boehringer Ingelheim in 1962 and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor. It was previously used for sedation in medical procedures such as surgery, orthopedics and gynecology, although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse. (en)
dbo:casNumber	2033-94-5
dbo:fdaUniiCode	3N20VGJ39Y
dbo:pubchem	16252
dbo:thumbnail	wiki-commons:Special:FilePath/Centalun.svg?width=300
dbo:wikiPageID	16689370 (xsd:integer)
dbo:wikiPageLength	3396 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	983328192 (xsd:integer)
dbo:wikiPageWikiLink	dbr:GABAA dbc:GABAA_receptor_positive_allosteric_modulators dbc:Hypnotics dbr:Allosteric dbr:Hypnotic dbr:Controlled_substances_act dbr:Sedative dbr:Psycholeptic
dbp:atcPrefix	none (en)
dbp:c	11 (xsd:integer)
dbp:casNumber	2033 (xsd:integer)
dbp:chemspiderid	15421 (xsd:integer)
dbp:h	12 (xsd:integer)
dbp:iupacName	2 (xsd:integer)
dbp:legalStatus	Unscheduled (en)
dbp:o	2 (xsd:integer)
dbp:pubchem	16252 (xsd:integer)
dbp:smiles	OCCC (en)
dbp:stdinchi	1 (xsd:integer)
dbp:stdinchikey	GQOXDWHRXDPZJK-UHFFFAOYSA-N (en)
dbp:unii	3 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	424810107 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:width	180 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Hypnotics_and_sedatives dbt:Drugbox dbt:GABAAR_PAMs dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Stdinchicite dbt:Sedative-stub
dcterms:subject	dbc:GABAA_receptor_positive_allosteric_modulators dbc:Hypnotics
gold:hypernym	dbr:Drug
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 yago:Agent114778436 yago:CausalAgent100007347 yago:Drug103247620 yago:Hypnagogue114913744 yago:Matter100020827 yago:PhysicalEntity100001930 yago:WikicatHypnotics dbo:Drug yago:Soporific104260934 yago:Substance100020090 umbel-rc:DrugProduct
rdfs:comment	Centalun was developed by Boehringer Ingelheim in 1962 and is a psycholeptic drug with hypnotic and sedative effects, via allosteric agonism of the GABAA receptor. It was previously used for sedation in medical procedures such as surgery, orthopedics and gynecology, although it is no longer in clinical use. Despite its history of clinical use, centalun was never incorporated into the CSA and therefore remains unregulated as a drug of abuse. (en)
rdfs:label	Centalun (en)
owl:sameAs	freebase:Centalun wikidata:Centalun dbpedia-sh:Centalun dbpedia-sr:Centalun https://global.dbpedia.org/id/4gikB yago-res:Centalun
prov:wasDerivedFrom	wikipedia-en:Centalun?oldid=983328192&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Centalun.svg
foaf:isPrimaryTopicOf	wikipedia-en:Centalun
is dbo:wikiPageWikiLink of	dbr:C11H12O2
is foaf:primaryTopic of	wikipedia-en:Centalun